Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

BCL7A anticorps (C-Term)

BCL7A Reactivité: Humain, Souris, Rat WB, ICC, IF, IHC (p) Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN2854648
  • Antigène Voir toutes BCL7A Anticorps
    BCL7A (B-Cell CLL/lymphoma 7A (BCL7A))
    Épitope
    • 15
    • 8
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    C-Term
    Reactivité
    • 33
    • 7
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    Humain, Souris, Rat
    Hôte
    • 32
    • 1
    Lapin
    Clonalité
    • 33
    Polyclonal
    Conjugué
    • 16
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp BCL7A est non-conjugé
    Application
    • 26
    • 18
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunocytochemistry (ICC), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Attributs du produit
    Rabbit Polyclonal antibody to BCL7A (B-cell CLL/lymphoma 7A)
    BCL7A antibody [C2C3], C-term
    Purification
    Purified by antigen-affinity chromatography.
    Immunogène
    Carrier-protein conjugated synthetic peptide encompassing a sequence within the C-terminus region of human BCL7A. The exact sequence is proprietary.
    Isotype
    IgG
  • Indications d'application
    Suggested dilution Reference ICC/IF 1:100-1:1000* IHC (Formalin-fixed paraffin-embedded sections) 1:100-1:1000* Western blot 1:500-1:3000* Not tested in other applications. *Optimal dilutions/concentrations should be determined by the researcher.Suggested dilutionReferenceICC/IF1:100-1:1000* IHC (Formalin-fixed paraffin-embedded sections)1:100-1:1000* Western blot1:500-1:3000*
    Commentaires

    Positive Control: HeLaS3 , Neuro2A , GL261

    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    1 mg/mL
    Buffer
    1XPBS, 20 % Glycerol ( pH 7). 0.01 % Thimerosal was added as a preservative.
    Agent conservateur
    Thimerosal (Merthiolate)
    Précaution d'utilisation
    This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C
    Stockage commentaire
    Keep as concentrated solution. Aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
  • Antigène
    BCL7A (B-Cell CLL/lymphoma 7A (BCL7A))
    Autre désignation
    BCL7A (BCL7A Produits)
    Synonymes
    anticorps BCL7, anticorps cb585, anticorps id:ibd1097, anticorps sb:cb585, anticorps wu:fk02d01, anticorps zgc:92023, anticorps 4432415N06Rik, anticorps AI448316, anticorps bcl7a, anticorps MGC89576, anticorps BCL7A, anticorps BCL tumor suppressor 7A, anticorps B-cell CLL/lymphoma 7A, anticorps B cell CLL/lymphoma 7A, anticorps B-cell CLL/lymphoma 7A L homeolog, anticorps BCL7A, anticorps bcl7a, anticorps Bcl7a, anticorps bcl7a.L
    Sujet
    This gene is directly involved, with Myc and IgH, in a three-way gene translocation in a Burkitt lymphoma cell line. As a result of the gene translocation, the N-terminal region of the gene product is disrupted, which is thought to be related to the pathogenesis of a subset of high-grade B cell non-Hodgkin lymphoma. The N-terminal segment involved in the translocation includes the region that shares a strong sequence similarity with those of BCL7B and BCL7C. Two transcript variants encoding different isoforms have been found for this gene.

    Poids moléculaire
    23 kDa
    ID gène
    605
Vous êtes ici:
Support technique